Fundz

Who to call at CollPlant Biotechnologies Ltd, and when

Fundz watches for the moments CollPlant Biotechnologies Ltd starts buying, and tells you who to reach.

  • An alert the day CollPlant Biotechnologies Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CollPlant Biotechnologies Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CollPlant Biotechnologies Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

CollPlant and Stratasys Initiate Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

Aug 19, 2024

Contract Type

partnership

RehovotManufacturingBiotechnologyHealthcare

Description

CollPlant Biotechnologies and Stratasys Ltd. have announced the initiation of a pre-clinical study focused on the development of bioprinting solutions and testing the ability of the implants to promote the growth of natural breast tissue. The study aims to provide a revolutionary alternative for reconstructive and aesthetic procedures in the breast implant market.

Quick answer

CollPlant and Stratasys Initiate Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (August 19, 2024). CollPlant Biotechnologies Ltd is based in Rehovot, Center District, Israel.

What agreement did CollPlant Biotechnologies Ltd announce on August 19, 2024?
CollPlant Biotechnologies and Stratasys Ltd. have announced the initiation of a pre-clinical study focused on the development of bioprinting solutions and testing the ability of the implants to promote the growth of natural breast tissue. The study aims to provide a revolutionary alternative for reconstructive and aesthetic procedures in the breast implant market.
What does CollPlant Biotechnologies Ltd do?
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics.
Where is CollPlant Biotechnologies Ltd based?
CollPlant Biotechnologies Ltd is based in Rehovot, Center District, Israel.

Source: Fundz verified event record.

Company Information

Company

CollPlant Biotechnologies Ltd

Location

Rehovot, Center District, Israel

About

CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.

Related People

Eran
Senior decision-maker at this company
••••••••@••••••••

See Eran's verified email →

Reut
Senior decision-maker at this company
••••••••@••••••••

See Reut's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CollPlant Biotechnologies Ltd's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

CollPlant Biotechnologies Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.